Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chiara Filisetti
Observed name:
C. Filisetti
Institutions:
IRCCS Ospedale San Raffaele,
The San Raffaele Telethon Institute for Gene Therapy
Observed institutions:
Vita-Salute San Raffaele University,
IRCCS Ospedale San Raffaele,
The San Raffaele Telethon Institute for Gene Therapy,
IRCCS San Raffaele Roma
ORCID:
0009-0004-1331-4997
Observed ORCID:
0009-0004-1331-4997
OpenAlex ID:
A5019919041
Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome
2024
·
Giulia Consiglieri
, Francesca Tucci
, et al.
·
Science Translational Medicine
·
28
Non-neurological, non-skeletal outcomes after hematopoietic stem and progenitor cell-gene therapy (OTL-203) for Hurler syndrome
2025
·
Francesca Tucci
, M. Luz Uria Oficialdegui
, et al.
·
Molecular Therapy
·
8
Ultrasonographic hip morphology in mucopolysaccharidosis type I Hurler after hematopoietic stem cell gene therapy
2025
·
Maurizio De Pellegrin
, Chiara Filisetti
, et al.
·
Journal of Children s Orthopaedics
·
2
First-in-human phase I/II clinical trial of hematopoietic stem and progenitor cell gene therapy for Hurler syndrome: Favorable safety profile and extensive metabolic correction
2022
·
Francesca Tucci
, Bernhard Gentner
, et al.
·
Molecular Genetics and Metabolism
·
1
PDF
Ps1220 Ex‐vivo Hematopoietic Stem Cell Gene Therapy (gt) for Mucopolysaccharidosis Type I Hurler (mpsih): Preliminary Results From a Phase I/ii Clinical Study
2019
·
M.E. Bernardo
, B. Gentner
, et al.
·
HemaSphere
·
1
How Does Hematopoietic Stem Cell Gene Therapy Affect Hip Dysplasia in Mucopolysaccharidosis Type I Hurler Syndrome? Radiological Outcomes at a Minimum 4-year Follow-up
2026
·
Maurizio De Pellegrin
, Matilde Cossutta
, et al.
·
Clinical Orthopaedics and Related Research
Hematopoietic stem cell gene therapy for mucopolysaccharidosis type I—Hurler syndrome (OTL-203): Interim skeletal, neurological and systemic outcomes from a phase I/II study
2025
·
Maria Ester M. Bernardo
, Francesca Tucci
, et al.
·
Molecular Genetics and Metabolism
P1392: Interim Analysis of First in Human Phase I-ii Clinical Trial of Ex-vivo Gene Therapy for Hurler Syndrome: an Update at 3 Year Follow-up
2023
·
Francesca Tucci
, Giulia Consiglieri
, et al.
·
HemaSphere
Show more works
View as search
Works count:
8
Citation count:
40
H-index:
2
I10-index:
1
Year
Topic
Type